FIELD: medicine.
SUBSTANCE: haemostatic values, endothelial dysfunction characteristics, diagnosed genetic forms of thrombophilia and habitual miscarriage are detected; the detected disorders are assessed in points depending on the gestational age. That is followed by calculating the total score, and therapy is prescribed depending on the total score. The case follow-up involves changing the therapeutic regimen with the total score variations.
EFFECT: method enables assessing objectively and standardising the therapeutic options in thrombophilic disorders accompanying pregnancy.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING SEVERE PREGNANCY COMPLICATIONS IN THROMBOPHILIC PATIENTS | 2008 |
|
RU2367446C1 |
| METHOD FOR PREVENTION OF PREECLAMPSIA IN CARRIERS OF F2G20210A MUTATION WITH SUPERTHRESHOLD INCREASE OF PROTHROMBIN ACTIVITY | 2019 |
|
RU2712444C1 |
| METHOD OF PREDICTING DEVELOPMENT OF MULTIFACTOR PATHOLOGY IN CHILDREN BORN WITH APPLICATION OF AUXILIARY REPRODUCTIVE TECHNOLOGIES | 2011 |
|
RU2456911C1 |
| METHOD FOR MANAGING PREGNANCY IN FEMALES SUFFERING FROM OVERWEIGHT | 2013 |
|
RU2527910C1 |
| METHOD FOR PREVENTING CHRONIC HYPOXIA AND FOETAL DEVELOPMENT RETARDATION | 2018 |
|
RU2699559C2 |
| METHOD OF PREECLAMPSIA PREVENTION IN PREGNANT WOMEN WITH MUTATION OF FACTOR V LEIDEN 1691 G/A | 2017 |
|
RU2666251C1 |
| METHOD OF PREVENTION OR TREATMENT OF INTRAUTERINE GROWTH RETARDATION SYNDROME | 2011 |
|
RU2473339C1 |
| METHOD FOR CORRECTION OF HAEMOSTASIS DISORDERS IN FEMALES ACCOMPANYING EXTRACORPOREAL FERTILIZATION | 2018 |
|
RU2723358C2 |
| METHOD FOR PREECLAMPSIA PREVENTION | 2011 |
|
RU2472506C1 |
| METHOD OF PREVENTING THROMBOTIC COMPLICATIONS OF PREGNANCY IN WOMEN WITH NON-DIFFERENTIATED FORMS OF MESENCHYMAL DYSPLASIA | 2012 |
|
RU2514045C2 |
